Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
---|---|---|---|---|---|---|
Vvi1g0217 | ATGTCTCGCCAAGTGGCCACGTCGCATTTCCACAAATCGAAGACTCTCGACAACAAATATATGCTTGGAGATGAGATCGGAAAAGGAGCATATGGTCGAGTTTACAAGGGTTTGGATTTGGAGAATGGAGACTTTGTTGCAATTAAACAAGTTTCTTTGGAGAATATTGCTCAAGAAGATCTCAACATTATCATGCAAGAGATTGATCTGCTCAAGAATTTGAACCACAAAAACATTGTGAAATATCTTGGATCTTTGAAGACAAGGAGTCATCTGCACATAATTCTTGAGTATGTGGAGAATGGCTCACTTGCAAACATCATCAAACCAAATAAATTTGGGCCATTTCCAGAATCACTGGTGGCTGTTTATATCTCTCAGGTCTTGGAGGGCTTGGTTTATCTACATGAACAAGGTGTCATCCATCGGGATATCAAGGGCGCAAATATATTGACAACCAAAGAGGGTCTTGTGAAACTTGCTGACTTTGGTGTTGCAACAAAATTAACTGAGGCAGATGTTAATACGCATTCCGTTGTTGGGACACCATATTGGATGGCCCCTGAGGTAATCGAAATGTCTGGGGTTTGTGCTGCTTCGGACATTTGGAGTGTTGGTTGCACTGTGATTGAGCTTCTTACATGTGTACCTCCTTACTATGATCTCCAGCCTATGCCAGCTCTATTCCGTATTGTTCAGGATGATCATCCTCCAATACCAGATGGCTTATCTACTGACATTACAGATTTTCTGCGGCAGTGTTTTAAGAAGGATGCTAGGCAGAGGCCTGATGCAAAGACACTGCTTTCACATCCTTGGATACGGAACTGTAGGCGTGCTTTGCAGTCCTCTCTTCGTCATAGTGGAACATTGAGAAATATACAGGAAGATGCTTCAGTTGATGCAGAGATTTCCAATGGAGATGATCAAAGTATTGGTGAAAGCCCTTCTGATGAGAAAGCAGAAGTAATTGCCTCTGAATTTGAAAATGATTCCAGAAAAGAGTGTTTACCAACTGAGGTTGTTGATACCGGCAAATCTTATACGGATTCCAATGGAGATCTTATTGAGGATGAAGTTGATAATCCAGAAGAGTATGTTCAATCAGATCAAGTACCCACATTGGCCATTCACGAAAAATCATCTCTACCAACTACTTCTGGTATATTGCCTGCTAATAAGGATGTGGCTCCCCCTAGTCCAACAGATTCTAACGAGGTACTAGATATGGGTGATCAGGATGAAGCACTAATGAATGGTAAGGTGGGATCTCCTAAGTCAAGAAAGAACAATGTTTTATATAAAAAGAGTGAAGGGAAAGGAAGTTCTACTCAACTTGACAACAGATTATTTGGTTTTGTACCAAGAAGTCAGGAGAATAGTTCTCGAAAGGCTGCAAAGGCACCAGTCATTTCGGGCGGAAATGAGCTAAGTAAATTTAGTGACACGCCAGGAGATGCTTCTTTGGAAGATTTATTTCATCCACTGCATAAGAATCCTGAGGATCAGGCAGCTGAAGCTTCAACATCTGCATCCTCATCACATGTTGTACAAGGCAATGCATTCATAAATGATGCTGGAAAAAATGACCTGGCAACAAAGTTGAGGGCTACAATTGCTCAGAAACAAATGGAGAATGAGATTGGGCAAACAAATGGAGATCTCTTCAGTTTAATGTTGGATGTTCTGAAGGAGGACGTGATGGATATTGATGGTTTGGTTTTTGATGACAAAATGCCTGGAGAGAACCTTTTTCCCCTACAGGCTGTTGAGTTTAGCAGATTAGTTGGGTCATTAAGACCACAGGAACCAGAAGATGTGATCGTGTCTGCCTGTTTGAAGCTTATATCCATTTTTCACCAACGCCCTGAGCAGAAAGGTGTGTTTGTTACTCAGCATGGTTTACTCCCCCTCATGGAACTACTTGAAGTTTCTAGAACTCGTGTTATATGTTCAGTGCTTCAAATTGTAAATCAGATAATCAAGGATAATACCGATTTCCAGGAAAATGCTTGTCTTGTTGGCCTGATCCCTGTTGTTATGAGCTTTGCAGTACCTGATCATCCCCGGGAAGTTCGCATGGAAGCCGCTTATTTCTCGCAGCAGCTTTGTCAGTCTAGCTCCTTGACATTGCAAATGTTCATTGCTTGTGGTGGAATACCTGTTTTAGTGGGCTTTCTGGAGGCTGATTATGTGAGGTACAGGGAAATGGTTCATCTAGCTATTGATGGCATGTGGCAGGTCTTCAAGCTTCAGCGATCAACACCTAGAAATGATTTCTGTCGCATTGCTGCAAAGAATGGAATACTTCCTAGGCTTATAAACACTCTTTATAGTTTGAATGAGGCTGCTCGTCTAGCTTCCATAGCTGGTGGTAGTGGATTTACAATAGAAGGTTTGGCTCCGCGACCACGTTCTGGTTCACTGGATCCCAGCTCTCCTATTTTTATTCAGGGTGAGATATCACTTACTGGAATCGATCATCCTGATCTCCTTAAGGTTAGGCATGGGCTAATTGATCATTCCTTGTCAACTGCAACCCAAGAACCTTCACGTGTTTCAGCATCACATCCCCAAAGGTCAGATGCTAACCAACCAGATTCCCGATACTTCTCTCTGGATACTGACAGGCCTGCAATGGAAGCTTCAGTTGCTTCTAAATTACAAGACCTTGCATTTTCAGAAAAAGTTGCAAATATGCAAACAAAGGAATCTTCTGGAACTATTTTGAAAGAGCGAGAAAACTTGGACCGCTGGAAAATTGATCCACAACGAGTCCCTAATTCGGCTAATAGGACATCAGTAGACAGACCTTCAAAATTGGTGGAAGGTGTGTCAAATGGGTTTCCTAGTACAATAGGGACCCAGCAAGAGCAAGTTCGACCTCTTCTTAGCTTGTTGGATAAGGAGCCCCCTTCCCGGCATTTTTCTGGTCAGCTAGAGTATGTACGGCACCTCTCTGGGTTGGAGAGACATGAAAGCATACTGCCTCTACTACATGCAACCAATGAGAAGAAAACAAATGGTGAACTAGATTTTCTGATGGCAGAATTTGCAGAGGTTTCTGGTCGTGGAAGAGAAAATGGAAATCTGGATTCTGCACCTAGAATTTCAAATAAAACTGTAAATAAGAAGATTCCATTGGCATCTAATGAGGGTGCTGCTTCTACATCTGGGATTGCTTCTCAGACAGCATCAGGTGTACTGTCTGGTTCTGGTGTTTTAAATGCTAGGCCAGGAAGTGCAACGTCATCTGGGTTGCTTTCCCATATGGTATCATCACTCAATGCTGATGTTGCTAAGGAATATCTAGAAAAGGTTGCAGACCTTCTGCTGGAGTTTGCCCAAGCAGATACGACAGTAAAATCCTACATGTGTAGCCAAAGCTTGCTTAGCCGTCTTTTTCAGATGTTCAATCGGATAGAGCCGCCTATTCTTTTGAAGATACTAAAGTGTATCAATCATTTGTCAACCGACCCAAATTGCTTAGAAAATCTTCAGCGTGCCGATGCAATCAAATACTTGATCCCAAACCTTGAACTCAAAGAAGGGCCTCTTGTATTTCAAATACATTATGAGGTCCTCTATGCATTATTCAACCTCTGCAAGATAAATAAGAGGAGGCAAGAACAAGCAGCTGAAAATGGAATCATTCCACACTTGATGCATTTTATAATGTCAGATTCTCCCTTGAAACAACATGCATTGCCTCTACTGTGCGATATGGCCCATGCATCACGTAACTCAAGGGAGCAATTAAGGGCCCATGATGGGTTGGATGTGTACTTAAGCCTACTTGAGGATGAGCTTTGGTCTGTGACAGCATTAGATTCTATTGCTGTGTGCTTGGCCCATGACAATGACAACCGGAAAGTAGAACAGGCGTTGCTGAAAAAGGATGCAATTCAGAAATTGGTCAAATTCTTCCAGTGCTGTCCTGAACAACATTTTGTGCACATATTGGAGCCCTTCTTGAAGATTATCACGAAATCATCCCGGATAAATACAACACTAGCTATTAATGGGTTGACACCCTTGCTTATTGCAAGGCTTGACCATCAGGATGCTATAGCTCGTCTTAATCTGCTCAAACTAATAAAGTCTGTTTATGAGCACCATCCACGGCCAAAGCAACTGATCGTGGAGAATGATCTGCCTCAGAAGCTTCAGAATCTGATTGAGGAGCGCAGAGATGGGCAACGTTCTGGAGGCCAAGTGTTGGTTAAACAGATGGCTACTTCTCTCCTTAAAGCACTCCATATCAACACCGTTTTGTAA | 4278 | 0.424 | MSRQVATSHFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYISQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYDLQPMPALFRIVQDDHPPIPDGLSTDITDFLRQCFKKDARQRPDAKTLLSHPWIRNCRRALQSSLRHSGTLRNIQEDASVDAEISNGDDQSIGESPSDEKAEVIASEFENDSRKECLPTEVVDTGKSYTDSNGDLIEDEVDNPEEYVQSDQVPTLAIHEKSSLPTTSGILPANKDVAPPSPTDSNEVLDMGDQDEALMNGKVGSPKSRKNNVLYKKSEGKGSSTQLDNRLFGFVPRSQENSSRKAAKAPVISGGNELSKFSDTPGDASLEDLFHPLHKNPEDQAAEASTSASSSHVVQGNAFINDAGKNDLATKLRATIAQKQMENEIGQTNGDLFSLMLDVLKEDVMDIDGLVFDDKMPGENLFPLQAVEFSRLVGSLRPQEPEDVIVSACLKLISIFHQRPEQKGVFVTQHGLLPLMELLEVSRTRVICSVLQIVNQIIKDNTDFQENACLVGLIPVVMSFAVPDHPREVRMEAAYFSQQLCQSSSLTLQMFIACGGIPVLVGFLEADYVRYREMVHLAIDGMWQVFKLQRSTPRNDFCRIAAKNGILPRLINTLYSLNEAARLASIAGGSGFTIEGLAPRPRSGSLDPSSPIFIQGEISLTGIDHPDLLKVRHGLIDHSLSTATQEPSRVSASHPQRSDANQPDSRYFSLDTDRPAMEASVASKLQDLAFSEKVANMQTKESSGTILKERENLDRWKIDPQRVPNSANRTSVDRPSKLVEGVSNGFPSTIGTQQEQVRPLLSLLDKEPPSRHFSGQLEYVRHLSGLERHESILPLLHATNEKKTNGELDFLMAEFAEVSGRGRENGNLDSAPRISNKTVNKKIPLASNEGAASTSGIASQTASGVLSGSGVLNARPGSATSSGLLSHMVSSLNADVAKEYLEKVADLLLEFAQADTTVKSYMCSQSLLSRLFQMFNRIEPPILLKILKCINHLSTDPNCLENLQRADAIKYLIPNLELKEGPLVFQIHYEVLYALFNLCKINKRRQEQAAENGIIPHLMHFIMSDSPLKQHALPLLCDMAHASRNSREQLRAHDGLDVYLSLLEDELWSVTALDSIAVCLAHDNDNRKVEQALLKKDAIQKLVKFFQCCPEQHFVHILEPFLKIITKSSRINTTLAINGLTPLLIARLDHQDAIARLNLLKLIKSVYEHHPRPKQLIVENDLPQKLQNLIEERRDGQRSGGQVLVKQMATSLLKALHINTVL* | 1426 |
Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
---|---|---|---|---|---|---|---|---|
Vvi1g0217 | 1425 | PRINTS | Tyrosine kinase catalytic domain signature | 96 | 109 | IPR001245 | GO:0004672|GO:0006468 | |
Vvi1g0217 | 1425 | PRINTS | Tyrosine kinase catalytic domain signature | 200 | 222 | IPR001245 | GO:0004672|GO:0006468 | |
Vvi1g0217 | 1425 | PRINTS | Tyrosine kinase catalytic domain signature | 134 | 152 | IPR001245 | GO:0004672|GO:0006468 | |
Vvi1g0217 | 1425 | PRINTS | Tyrosine kinase catalytic domain signature | 243 | 265 | IPR001245 | GO:0004672|GO:0006468 | |
Vvi1g0217 | 1425 | PANTHER | MITOGEN-ACTIVATED KINASE KINASE KINASE | 17 | 736 | - | - | |
Vvi1g0217 | 1425 | FunFam | MAP3K epsilon protein kinase 1 | 17 | 306 | - | - | |
Vvi1g0217 | 1425 | MobiDBLite | consensus disorder prediction | 845 | 873 | - | - | |
Vvi1g0217 | 1425 | FunFam | MAP3K epsilon protein kinase 1-like | 1074 | 1420 | - | - | |
Vvi1g0217 | 1425 | Pfam | Protein kinase domain | 21 | 274 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vvi1g0217 | 1425 | Gene3D | - | 584 | 792 | IPR011989 | - | |
Vvi1g0217 | 1425 | ProSitePatterns | Protein kinases ATP-binding region signature. | 26 | 49 | IPR017441 | GO:0005524 | |
Vvi1g0217 | 1425 | CDD | STKc_Cdc7_like | 19 | 274 | - | - | |
Vvi1g0217 | 1425 | SMART | serkin_6 | 20 | 274 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vvi1g0217 | 1425 | MobiDBLite | consensus disorder prediction | 296 | 318 | - | - | |
Vvi1g0217 | 1425 | Gene3D | - | 1075 | 1422 | IPR011989 | - | |
Vvi1g0217 | 1425 | SUPERFAMILY | ARM repeat | 1086 | 1399 | IPR016024 | - | |
Vvi1g0217 | 1425 | SMART | arm_5 | 622 | 662 | IPR000225 | GO:0005515 | |
Vvi1g0217 | 1425 | SMART | arm_5 | 1159 | 1203 | IPR000225 | GO:0005515 | |
Vvi1g0217 | 1425 | SMART | arm_5 | 707 | 750 | IPR000225 | GO:0005515 | |
Vvi1g0217 | 1425 | SMART | arm_5 | 1205 | 1244 | IPR000225 | GO:0005515 | |
Vvi1g0217 | 1425 | SUPERFAMILY | Protein kinase-like (PK-like) | 17 | 275 | IPR011009 | - | |
Vvi1g0217 | 1425 | MobiDBLite | consensus disorder prediction | 384 | 493 | - | - | |
Vvi1g0217 | 1425 | ProSitePatterns | Serine/Threonine protein kinases active-site signature. | 140 | 152 | IPR008271 | GO:0004672|GO:0006468 | |
Vvi1g0217 | 1425 | MobiDBLite | consensus disorder prediction | 436 | 465 | - | - | |
Vvi1g0217 | 1425 | FunFam | MAP3K epsilon protein kinase 1 | 584 | 792 | - | - | |
Vvi1g0217 | 1425 | MobiDBLite | consensus disorder prediction | 845 | 871 | - | - | |
Vvi1g0217 | 1425 | Gene3D | Transferase(Phosphotransferase) domain 1 | 17 | 311 | - | - | |
Vvi1g0217 | 1425 | MobiDBLite | consensus disorder prediction | 922 | 953 | - | - | |
Vvi1g0217 | 1425 | ProSiteProfiles | Protein kinase domain profile. | 20 | 274 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vvi1g0217 | 1425 | SUPERFAMILY | ARM repeat | 593 | 787 | IPR016024 | - |
Select | Gene | Chromosome | Start | End | Duplicated_type |
---|---|---|---|---|---|
Vvi1g0217 | Vvi-Chr1 | 2007333 | 2038877 | Dispersed/Transposed |
Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
---|---|---|---|---|---|---|---|---|
Vvi1g0217 | 1 | 1425 | MAP Kinase Kinase Kinase | AT3G13530 | 73.394 | 0.0 | 2058 |